Juan Tao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Juan Tao has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Caofeng Pan
Key Laboratory of Materials Processing and Mold (Zhengzhou University) Ministry of Education School of Materials Science and Engineering Zhengzhou University Zhengzhou Henan People's Republic of China
3 shared publications - Jing Li
CAS Center for Excellence in Nanoscience, Beijing Key Laboratory of Micro-nano Energy and Sensor, Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences 1 , Beijing 100083
2 shared publications - Rongrong Bao
Beijing Key Laboratory for Atomic Manufacturing Equipment and Intelligent Sensing Institute of Atomic Manufacturing Beihang University Beijing People's Republic of China
2 shared publications - Chunfeng Wang
Guangdong Research Center for Interfacial Engineering of Functional Materials, Guangdong Provincial Key Laboratory of New Energy Materials Service Safety, College of Materials Science and Engineering, Shenzhen University
1 shared publication - Dengfeng Peng
Shenzhen University
1 shared publication Jieping Pan
1 shared publication
Latest Publications
- 1 December 2021
- Published by Elsevier in Science Bulletin
- Vol. 66 (24) , 2437-2439
A multimodal ion electronic skin for decoupling temperature and strain
- 1 December 2021
- Published by Elsevier in Science Bulletin
- Vol. 66 (24) , 2437-2439
A multimodal ion electronic skin for decoupling temperature and strain
- 18 February 2020
- Published by AIP Publishing in Applied Physics Reviews
- Vol. 7 (1) , 011404
Visually aided tactile enhancement system based on ultrathin highly sensitive crack-based strain sensors
Attenuated tactile sensation may occur on people who have skin trauma or prolonged glove usage. Such decreased sensation may cause patients to become less responsive to minute skin deformations and consequently fail to regulate their limbs properly. To mitigate such health conditions, an integrated tactile enhancement system that exceeds the human skin's sensitivity is indispensable for patients to regain the touch sensation of minute deformations. Here, we develop a visually aided tactile enhancement system for precise motion control by combining ultrathin, highly sensitive, crack-based strain sensors and signal acquisition circuit with real-time display equipment. By optimizing the thicknesses of the substrates and sensitive films of the strain sensors, our device has a detection limit as low as 0.01% and an ultrahigh gauge factor of 44 013 at a strain of 0.88%, which exceeds the performance of previous devices with crack-based strain sensors within minute strain range. The high sensitivity of the ultrathin crack-based strain sensor makes it possible for our visually aided tactile enhancement system to detect tiny deformations such as the slight brush of a feather, the fall of water droplets on fingers, and even the touch of invisible wires. Our study demonstrates promising applications of integrated visually aided tactile enhancement systems in human-machine interactions and artificial intelligence.
- 18 February 2020
- Published by AIP Publishing in Applied Physics Reviews
- Vol. 7 (1) , 011404
Visually aided tactile enhancement system based on ultrathin highly sensitive crack-based strain sensors
Attenuated tactile sensation may occur on people who have skin trauma or prolonged glove usage. Such decreased sensation may cause patients to become less responsive to minute skin deformations and consequently fail to regulate their limbs properly. To mitigate such health conditions, an integrated tactile enhancement system that exceeds the human skin's sensitivity is indispensable for patients to regain the touch sensation of minute deformations. Here, we develop a visually aided tactile enhancement system for precise motion control by combining ultrathin, highly sensitive, crack-based strain sensors and signal acquisition circuit with real-time display equipment. By optimizing the thicknesses of the substrates and sensitive films of the strain sensors, our device has a detection limit as low as 0.01% and an ultrahigh gauge factor of 44 013 at a strain of 0.88%, which exceeds the performance of previous devices with crack-based strain sensors within minute strain range. The high sensitivity of the ultrathin crack-based strain sensor makes it possible for our visually aided tactile enhancement system to detect tiny deformations such as the slight brush of a feather, the fall of water droplets on fingers, and even the touch of invisible wires. Our study demonstrates promising applications of integrated visually aided tactile enhancement systems in human-machine interactions and artificial intelligence.
- 17 August 2018
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 6 (44) , 11878-11892
Recent progress in flexible pressure sensor arrays: from design to applications
This review summarizes the progress in flexible pressure sensor arrays from their fundamental designs to device applications.
- 17 August 2018
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 6 (44) , 11878-11892
Recent progress in flexible pressure sensor arrays: from design to applications
This review summarizes the progress in flexible pressure sensor arrays from their fundamental designs to device applications.
- 8 April 2014
- Vol. 94 (13) , 973-6
[Clinical features and prognosis of patients with lupus nephritis].
To explore the clinical features and prognosis of patients with lupus nephritis (LN) in a large multicenter lupus cohort of Jiangsu Province. Medical records of 2 078 systemic lupus erythematosus (SLE) inpatients from 15 hospitals at the first admission from 1999 to 2012 were reviewed and classified into two groups with LN or without. The clinical features between two groups were compared with Mann-Whitney U or Chi-square test and potentially associated factors tested by Cox regression. A total of 883 (42.5%) hospitalized lupus patients were diagnosed as LN. And the median age at disease onset of LN patients was lower than that of those without LN [(30 ± 11) vs (32 ± 12) years, P < 0.01]. Cardiopulmonary involvement, neuropsychiatric disorder, gastrointestinal dysfunction, hematologic disease, ophthalmopathy, SLEDAI score > 9 at admission and SLE disease activity index (SLEDAI) score > 9 at discharge were more often seen in patients with LN compared to those without LN (31.5%, 7.9%, 13.9%, 69.0%, 1.5%, 77.4%, 29.8% vs 18.8%, 5.1%, 6.8%, 63.1%, 0.3%, 43.1%, 8.1%, all P < 0.01). The mortality rates at 1 or 5 years after first admission were both significantly higher in LN patients than those without LN (7.2%, 15.0% vs 3.1%, 6.3%, P < 0.01). Independent predictors for mortality in patients with LN were neuropsychiatric involvement[hazard ratio (HR) 2.46], SLEDAI score > 9 at discharge (HR 2.34), increased serum creatinine (HR 2.21) and elevated alanine aminotransferase and (or) aspartate transaminase (HR 2.09) whereas glucocorticosteroid therapy (HR 0.18) was a protective factor. LN is one common complication of SLE patients during an early stage. And LN patients are more prone to present other vital organ involvement, higher disease activity and worse treatment outcomes. When accompanied with neuropsychiatric involvement, increased serum creatinine or elevated transaminase, worse prognosis is expected. Glucocorticosteroid treatment may offer some benefits.
- 8 April 2014
- Vol. 94 (13) , 973-6
[Clinical features and prognosis of patients with lupus nephritis].
To explore the clinical features and prognosis of patients with lupus nephritis (LN) in a large multicenter lupus cohort of Jiangsu Province. Medical records of 2 078 systemic lupus erythematosus (SLE) inpatients from 15 hospitals at the first admission from 1999 to 2012 were reviewed and classified into two groups with LN or without. The clinical features between two groups were compared with Mann-Whitney U or Chi-square test and potentially associated factors tested by Cox regression. A total of 883 (42.5%) hospitalized lupus patients were diagnosed as LN. And the median age at disease onset of LN patients was lower than that of those without LN [(30 ± 11) vs (32 ± 12) years, P < 0.01]. Cardiopulmonary involvement, neuropsychiatric disorder, gastrointestinal dysfunction, hematologic disease, ophthalmopathy, SLEDAI score > 9 at admission and SLE disease activity index (SLEDAI) score > 9 at discharge were more often seen in patients with LN compared to those without LN (31.5%, 7.9%, 13.9%, 69.0%, 1.5%, 77.4%, 29.8% vs 18.8%, 5.1%, 6.8%, 63.1%, 0.3%, 43.1%, 8.1%, all P < 0.01). The mortality rates at 1 or 5 years after first admission were both significantly higher in LN patients than those without LN (7.2%, 15.0% vs 3.1%, 6.3%, P < 0.01). Independent predictors for mortality in patients with LN were neuropsychiatric involvement[hazard ratio (HR) 2.46], SLEDAI score > 9 at discharge (HR 2.34), increased serum creatinine (HR 2.21) and elevated alanine aminotransferase and (or) aspartate transaminase (HR 2.09) whereas glucocorticosteroid therapy (HR 0.18) was a protective factor. LN is one common complication of SLE patients during an early stage. And LN patients are more prone to present other vital organ involvement, higher disease activity and worse treatment outcomes. When accompanied with neuropsychiatric involvement, increased serum creatinine or elevated transaminase, worse prognosis is expected. Glucocorticosteroid treatment may offer some benefits.